Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P King

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Toxicologic Pathology|April 30, 2014
Nonclinical safety biomarkers of drug-induced vascular injury: current status and blueprint for the futureIgor Mikaelian, Mark Cameron, Deidre A Dalmas, et al.
Plos Medicine|November 30, 2007
Clinical trials and medical care: defining the therapeutic misconceptionGail E Henderson, Larry R Churchill, Arlene M Davis, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 2, 2016
Evaluation of the Relative Performance of Drug-Induced Skeletal Muscle Injury Biomarkers in RatsPeter M Burch, David Greg Hall, Elizabeth G Walker, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|January 8, 2013
Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging fieldLeili Fatehi, Susan M Wolf, Jeffrey McCullough, et al.
The Hastings Center Report|December 9, 2022
Clarifying the Ethics and Oversight of Chimeric ResearchJosephine Johnston, Insoo Hyun, Carolyn P Neuhaus, et al.
Hepatology (Baltimore, Md.)|January 23, 2018
Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effortRachel J Church, Gerd A Kullak-Ublick, Jiri Aubrecht, et al.
BMC Pediatrics|July 19, 2019
Early Check: translational science at the intersection of public health and newborn screeningDonald B Bailey, Lisa M Gehtland, Megan A Lewis, et al.
The New England Journal of Medicine|June 28, 2013
The OHRP and SUPPORT--another viewRuth Macklin, Lois Shepherd, Alice Dreger, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Toxicologic Pathology|April 30, 2014
Nonclinical safety biomarkers of drug-induced vascular injury: current status and blueprint for the futureIgor Mikaelian, Mark Cameron, Deidre A Dalmas, et al.
Plos Medicine|November 30, 2007
Clinical trials and medical care: defining the therapeutic misconceptionGail E Henderson, Larry R Churchill, Arlene M Davis, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 2, 2016
Evaluation of the Relative Performance of Drug-Induced Skeletal Muscle Injury Biomarkers in RatsPeter M Burch, David Greg Hall, Elizabeth G Walker, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|January 8, 2013
Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging fieldLeili Fatehi, Susan M Wolf, Jeffrey McCullough, et al.
The Hastings Center Report|December 9, 2022
Clarifying the Ethics and Oversight of Chimeric ResearchJosephine Johnston, Insoo Hyun, Carolyn P Neuhaus, et al.
Hepatology (Baltimore, Md.)|January 23, 2018
Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effortRachel J Church, Gerd A Kullak-Ublick, Jiri Aubrecht, et al.
BMC Pediatrics|July 19, 2019
Early Check: translational science at the intersection of public health and newborn screeningDonald B Bailey, Lisa M Gehtland, Megan A Lewis, et al.
The New England Journal of Medicine|June 28, 2013
The OHRP and SUPPORT--another viewRuth Macklin, Lois Shepherd, Alice Dreger, et al.
Pageof 14